Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company's products are used in textiles, pharmaceuticals, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.
Frequently asked questions
What sector does Cathay Biotech Inc (688065) operate in?
Cathay Biotech Inc belongs to the Materials sector and operates in the Chemicals industry.
What is Cathay Biotech Inc (688065) current stock price?
As of the latest data, Cathay Biotech Inc stock price is CN¥37.48, with a previous close of CN¥37.48.
What is Cathay Biotech Inc (688065) current market capitalization?
Cathay Biotech Inc market cap is approximately 27.03 billion.
What is Cathay Biotech Inc (688065) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.87, and the forward EPS is CN¥1.31.
What is Cathay Biotech Inc (688065) Price-to-Earnings (P/E) ratio?
Cathay Biotech Inc current P/E ratio is 43.08, with a forward P/E of 28.61.
Does Cathay Biotech Inc (688065) pay dividends?
Yes. Cathay Biotech Inc pays annual dividends with an annualized yield of 1.2% and an estimated annual payout of CN¥0.45 per share.
When is the next ex-dividend date for Cathay Biotech Inc (688065)?
The next ex-dividend date is scheduled for July 29, 2027.
What is Cathay Biotech Inc (688065) beta (volatility) score?
Cathay Biotech Inc has a beta of 0.413, indicating lower volatility than the overall market.
